Dianthus Therapeutics
DNTH
DNTH
94 hedge funds and large institutions have $211M invested in Dianthus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
23% less capital invested
Capital invested by funds: $276M → $211M (-$64.5M)
94% less call options, than puts
Call options by funds: $3K | Put options by funds: $52K
Holders
94
Holding in Top 10
2
Calls
$3K
Puts
$52K
Top Buyers
| 1 | +$3.03M | |
| 2 | +$1.59M | |
| 3 | +$506K | |
| 4 |
BL
Bleichroeder LP
New York
|
+$222K |
| 5 |
State Street
Boston,
Massachusetts
|
+$183K |
Top Sellers
| 1 | -$3.72M | |
| 2 | -$3.48M | |
| 3 | -$1.97M | |
| 4 |
EP
Eversept Partners
New York
|
-$1.45M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.11M |